CUH Logo

Mobile menu open

Slavery and human trafficking statement 2023/24

Modern slavery is the recruitment, movement, harbouring or receiving of people through the use of force, coercion, abuse of vulnerability, deception or other means for the purpose of exploitation.

Individuals may be trafficked into, out of, or within the UK. They may be trafficked for a number of reasons, including sexual exploitation, forced labour, domestic servitude and organ harvesting.

Cambridge University Hospitals NHS Foundation Trust (CUH) is committed to upholding the provisions of the Modern Slavery Act 2015 and to ensuring that there is no modern slavery or human trafficking in any part of our business.

We expect our staff and our suppliers to comply with this legislation.

CUH will:

  • Continue to develop awareness within the Trust of modern slavery issues.
  • Ensure that Procurement staff receive regular updates and training so that they are aware of legislative requirements in this area.
  • Consider modern slavery factors when making procurement decisions.
  • Make suppliers and service providers aware that we expect them to understand and adhere to the requirements of the legislation.
  • Use NHS Terms and Conditions for Goods and Services for specification and tender documents which require suppliers to comply with all relevant legislation and guidance, including modern slavery conditions.
  • Adhere to national NHS employment checks and standards.
  • Only work with NHS framework approved agencies for the recruitment and placement of workers and employees, auditing compliance with safe recruitment practice.
  • Ensure that all staff undertake mandatory Safeguarding Children and Vulnerable Adults training, and mandatory training in Equality, Diversity and Inclusion.
  • Ensure that modern slavery and human trafficking is reflected in the Trust’s safeguarding policies and work plans.
  • Maintain robust Freedom to Speak Up arrangements which allow staff and others to raise concerns in confidence.

Approved by the Board of Directors: 8 March 2023